Ginsenoside Rh2 inhibits GLUT1-mediated aerobic glycolysis in tumor cells, and its role as a tumor energy blocker may be responsible for the inhibition of CSC self-renewal (Liu X Y et al., 2020). This evidence concerns the gene SLC2A1 and neoplasm.